Evidence map›Paper›PMID 34176283›Full record

ArticleHypertension (Dallas, Tex. : 1979)2021

Targeting MicroRNA-192-5p, a Downstream Effector of NOXs (NADPH Oxidases), Reverses Endothelial DHFR (Dihydrofolate Reductase) Deficiency to Attenuate Abdominal Aortic Aneurysm Formation.

Kai Huang, Taro Narumi, Yixuan Zhang, Qiang Li, Priya Murugesan, Yusi Wu, Norika Mengchia Liu, Hua Cai

Open access · bronzeAbstract read
In one paragraph

Article in Hypertension (Dallas, Tex. : 1979), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Kai Huang *Division of Molecular Medicine, Department of Anesthesiology (K.H., T.N., Y.Z., Q.L., P.M., Y.W., N.M.L., H.C.), David Geffen School of Medicine, University of California Los Angeles.
Taro Narumi *Division of Molecular Medicine, Department of Anesthesiology (K.H., T.N., Y.Z., Q.L., P.M., Y.W., N.M.L., H.C.), David Geffen School of Medicine, University of California Los Angeles.
Yixuan ZhangDivision of Molecular Medicine, Department of Anesthesiology (K.H., T.N., Y.Z., Q.L., P.M., Y.W., N.M.L., H.C.), David Geffen School of Medicine, University of California Los Angeles.
Qiang LiDivision of Molecular Medicine, Department of Anesthesiology (K.H., T.N., Y.Z., Q.L., P.M., Y.W., N.M.L., H.C.), David Geffen School of Medicine, University of California Los Angeles.
Priya MurugesanDivision of Molecular Medicine, Department of Anesthesiology (K.H., T.N., Y.Z., Q.L., P.M., Y.W., N.M.L., H.C.), David Geffen School of Medicine, University of California Los Angeles.
Yusi WuDivision of Molecular Medicine, Department of Anesthesiology (K.H., T.N., Y.Z., Q.L., P.M., Y.W., N.M.L., H.C.), David Geffen School of Medicine, University of California Los Angeles.
Norika Mengchia LiuDivision of Molecular Medicine, Department of Anesthesiology (K.H., T.N., Y.Z., Q.L., P.M., Y.W., N.M.L., H.C.), David Geffen School of Medicine, University of California Los Angeles.
Hua CaiDivision of Molecular Medicine, Department of Anesthesiology (K.H., T.N., Y.Z., Q.L., P.M., Y.W., N.M.L., H.C.), David Geffen School of Medicine, University of California Los Angeles.
University of California, Los Angeles · US

Funding

Angiotensin II Uncoupling of Enos in HypertensionR01HL077440 · NHLBI · UNIVERSITY OF CHICAGO · PI CAI, HUA LINDA · 2005 to 2019
$4.8M
NOXs, eNOS Uncoupling and Diabetic AtherogenesisR01HL088975 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CAI, HUA LINDA · 2010 to 2019
$4.5M
Targeting NOX4-dependent mitochondrial dysfunction, autophagy and defective calcium handling in AFR01HL162407 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CAI, HUA LINDA, GOLDHABER, JOSHUA I · 2022 to 2025
$2.8M
Phenotypes and mechanisms of pulmonary hypertension-driven cognitive impairment and Alzheimer's diseaseR01HL154754 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CAI, HUA LINDA, MAKINO, AYAKO · 2020 to 2023
$2.5M
Netrin-1 and Netrin-1 Preconditioned EPCs in Vascular ProtectionR01HL142951 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CAI, HUA LINDA · 2020 to 2023
$2.0M
NHLBI NIH HHS R01 HL077440NHLBI NIH HHS R01 HL088975NHLBI NIH HHS R01 HL142951NHLBI NIH HHS R01 HL154754NHLBI NIH HHS R01 HL162407
6 · The paper itself

Abstract

[Figure: see text].

Indexed as

AgedAged, 80 and overAortaAortic Aneurysm, AbdominalDown-RegulationEndothelial CellsEndothelium, VascularFemaleHumansHydrogen PeroxideMaleMicroRNAsMiddle AgedNADPH OxidasesNitric OxideNitric Oxide Synthase Type IIIHydrogen PeroxideMicroRNAsMIRN192 microRNA, humanNADPH OxidasesNitric OxideNitric Oxide Synthase Type IIITetrahydrofolate Dehydrogenaseangiotensin IIaortic aneurysm, abdominaldihydrofolate reductaseendothelial nitric oxide synthasemicroRNANADPH oxidaseoxidative stress

Identifiers

PMID34176283
PMCPMC8266749
OpenAlexW3174600171

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.